Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-[beta]1b : study protocol for a randomized controlled trial

Background It had been more than 5 years since the first case of Middle East Respiratory Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has been investigated in randomized clinical trials. Results from in vitro and animal studies suggest that a combination of lopin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Trials 2018-01, Vol.19 (1)
Hauptverfasser:	Arabi, Yaseen M, Alothman, Adel, Balkhy, Hanan H, Al-Dawood, Abdulaziz, AlJohani, Sameera, Al Harbi, Shmeylan, Kojan, Suleiman, Al Jeraisy, Majed, Deeb, Ahmad M, Assiri, Abdullah M, Al-Hameed, Fahad, AlSaedi, Asim, Mandourah, Yasser, Almekhlafi, Ghaleb A, Sherbeeni, Nisreen Murad, Elzein, Fatehi Elnour, Memon, Javed, Taha, Yusri, Almotairi, Abdullah, Maghrabi, Khalid A, Qushmaq, Ismael, Al Bshabshe, Ali, Kharaba, Ayman, Shalhoub, Sarah, Jose, Jesna, Fowler, Robert A, Hayden, Frederick G, Hussein, Mohamed A,
Format:	Artikel
Sprache:	eng
Schlagworte:	Comparative analysis Complications and side effects Dosage and administration Drug therapy Health aspects Interferon beta Lopinavir Middle East respiratory syndrome Ritonavir
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!